News

Thirst is a crucial physiological signal that contributes to the survival of humans and other animals, by allowing them to ...
Adopting new digital systems to help oceangoing container ships get in line to offload their cargo at busy ports appears to ...
Plug Power shares rise after its Georgia plant hits record hydrogen output, reinforcing its leadership in U.S. clean energy ...
Nanomedicines, especially those based on nanoparticles, are revolutionizing health care in terms of both diagnostics and ...
BioAffinity Technologies Inc. (NASDAQ:BIAF) announced that the US Patent and Trademark Office/USPTO has issued a new patent. The patent is titled “Compositions and Methods for Treating Cancer,” and ...
The pivotal AMPLIFY trial aims to support FDA approval of ⁶⁴Cu-SAR-bisPSMA as a best-in-class imaging tool in prostate cancer ...
Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to ...
Stevens-Johnson syndrome and its more severe variant, toxic epidermal necrolysis, are rare and dangerous immunologic diseases ...
Following successful clinical implementations in the U.S., Inspira accelerates commercialization of its system. The Company is already engaged in discussions with governmental health departments and ...
The aim of this trial is to investigate the ability of 64 Cu-SAR-bisPSMA PET/computed tomography (CT) to detect recurrence of prostate cancer, with evaluation across 2 imaging timepoints, Day 1 (day ...
Lacerta Group LLC announced the rollout of its Seal N’ Flip packaging.
An international team led by HZB chemist Michelle Browne conducted a rigorous investigation that demonstrated the potential ...